Glaucoma News

A case-crossover study conducted on a large health care database in South Korea shed light on the association between acute angle-closure glaucoma and a number of prescription and nonprescription medications.

Glaukos reported positive results in a clinical trial investigating the safety of the surgical exchange procedure for the iDose TR in subjects who had previously received the implant in a phase 2b clinical trial.

Lack of treatment and poor patient compliance with medication are major concerns in the management of primary open-angle glaucoma, researchers reported in Patient Preference and Adherence.

SAN DIEGO — Results from a pilot study showed that low-dose doxycycline may hold promise as an adjunct treatment for IOP reduction, according to a poster presented at Academy 2022.

An increased risk for primary open-angle glaucoma was found in individuals with higher systolic blood and pulse pressures, while no statistically significant link was found in those with elevations in diastolic or mean arterial pressures.

In this exclusive surgical video for Healio/OSN, I. Paul Singh, MD, uses the iStent infinite to inject three heparin-coated titanium stents into the anterior chamber of an eye with uncontrolled primary open-angle glaucoma.

The top Healio/OSN articles about glaucoma in 2022 included a report about the increased risk for glaucoma in patients on antihypertensive therapy with frequent dietary salt intake.

With the growing prevalence of myopia and concern about its long-term complications, many optometrists are offering myopia management for pediatric patients, to hopefully limit the progression of their myopia.

High IOP variability was associated with faster rate of retinal nerve fiber thinning over time in a cohort of patients with open-angle glaucoma, according to a study published in JAMA Ophthalmology.

Bausch + Lomb and Glaucoma Research Foundation have launched the “Screen, Protect, Cure” campaign to raise glaucoma awareness.